Pink has almost replaced orange as the
color of October, thanks to National Breast Cancer
Awareness Month. Don’t forget that all those pink
ribbons are meant to remind you of the importance of
mammograms, which can sometimes detect breast cancer in
its most treatable stages. Join us this week as we
feature a new screening option for women with a high
genetic risk for breast cancer and an explanation of
breast cancer’s different stages.
Also in this
week’s newsletter: Detecting heart disease with an
exercise test—and how people with chronic myeloid
leukemia can keep track of their treatment
progress.
More
Than Mammograms: MRI for High-Risk
Women
Physicians
and women have long wanted a better breast
cancer screening test than a mammogram. A recent
study suggests that a new option, magnetic
resonance imaging (MRI), can be added to the
screening arsenal, though it’s only recommended
to women at high genetic risk for breast
cancer.
Breast cancer
stages tell us the characteristics of the cancer
and if it has spread beyond the breast tissue.
Doctors can use this information to guide
treatment decisions. Learn how staging is vital
in determining next steps.
An exercise
stress test, where the heart is monitored while
you walk or run on a treadmill or ride a
stationary bicycle, can help certain people
uncover their heart disease risk. Two new
studies demonstrate what group of people should
get the test.
Blood tests
are routine in the treatment of chronic myeloid
leukemia. Hear how one patient learned how to
follow her treatment progress by studying her
complicated lab tests.
The CML Medical Monitor
is an interactive health tool and educational resource
for people living with chronic myeloid leukemia. The CML
Medical Monitor was designed in collaboration with CML
medical experts and patients, to help people living with
CML keep track of their symptoms and treatment
progress.
